Vicore Pharma Holding AB (publ) has appointed the Nomination Committee for the 2024 Annual General Meeting. The three largest shareholders as of August 31, 2023 have been each appointed a member to the Nomination Committee, in accordance with the decision taken at the Annual General Meeting on May 11, 2021. The Nomination Committee consists of Staffan Lindstrand, appointed by HealthCap VII L.P., Jan Särlvik, appointed by the Fourth Swedish National Pension Fund, and Ivo Staijen, appointed by HBM Healthcare Investments (Cayman) Ltd. Vicore's chairman, Jacob Gunterberg, is also a member and acts as the convener of the Committee.

The task of the Nomination Committee is to prepare and present proposals for the number of board members to be elected by the AGM, the election of a chairman and other members of the board, board fees, remuneration for committee work, election of a chairman to the Annual General Meeting, election of auditors, and auditors' fees, and proposals for rules for the appointment of a nomination committee for the Annual General Meeting 2025.